Background
==========

Gastric cancer is the second most frequent malignancy worldwide and the prognosis of this malignancy remains very poor \[[@B1]\]. Gastric cancer incidence and mortality rates differ between different countries within the European Union \[[@B2]\]. In the Netherlands it ranks fifth as a cause of cancer death, with approximately 2,200 new cases each year \[[@B3]\]. Surgery with curative intent is the treatment of choice in advanced cases of gastric cancer, whereas local endoscopic mucosectomy can be curative in early gastric cancer. Detection and removal of gastric neoplasias in an early or even premalignant state will contribute to reduce death due to gastric cancer. To achieve this goal, better tests for early detection of gastric cancer are needed, and an improved understanding of the biology of gastric cancer progression is crucial in this respect.

According to the Correa model, pathogenesis of intestinal-type gastric adenocarcinoma follows a pathway of chronic active gastritis due to *Helicobacter pylori*infection, leading to mucosal atrophy, intestinal metaplasia followed by intraepithelial neoplasia and finally invasive adenocarcinoma \[[@B4]\]. Genetic characterization of tissue samples in intraepithelial neoplasia stage would substantially contribute to our understanding of the molecular pathogenesis of gastric cancer. However, these lesions are only rarely detected, possibly due to rapid progression through this stage towards cancer, and are usually present only in parts of biopsy specimens, hampering genomic analysis of these lesions. Analysis of alternative precursor lesions could therefore, at least partly, be a substitute. Development of gastric cancer through an adenoma stage, although less common, is such alternative route. These adenomas are occasionally detected during gastroscopy and present as large lesions that histologically show intra-epithelial neoplasia, which makes them suitable for genomic analysis. Gastric adenomas have a direct malignant potential and account for approximately 20% of all epithelial polyps \[[@B5],[@B6]\]. Gastric adenomas can have a classic tubular, tubulovillous, or villous morphology with a predominantly intestinal-type epithelium, but can also appear as pyloric gland adenomas \[[@B6]\]. Pyloric gland adenomas arise from deep mucoid glands in the stomach and are strongly positive for mucin 6 \[[@B7],[@B8]\]. A substantial number of gastric adenomas already show progression to adenocarcinoma. On first diagnosis around 30--40% of all pyloric gland adenomas already show a focus of carcinoma \[[@B9],[@B10]\]. For intestinal-type adenomas this number is lower and varies from 28,5% for villous adenomas and 29.4% for tubulovillous type adenomas to only 5.4% in the tubular adenomas \[[@B11]\]. Both adenocarcinomas, ex intestinal-type adenomas and ex pyloric gland adenomas, show glandular structures, in contrast to diffuse type gastric cancer.

A key feature in the pathogenesis of most gastric cancers, as in many other solid cancers, is chromosomal instability, resulting in gains and losses of parts or even whole chromosomes \[[@B12]\]. These chromosomal changes can be analyzed by comparative genomic hybridization (CGH). Several previous studies have detected genetic alterations in gastric adenomas using this technique, being gains on chromosome 7q, 8q, 13q, 20q, and losses on chromosome 4p, 5q, 9p 17p and 18q \[[@B13]-[@B16]\]. Although uncommon and only observed in adenomas with high grade intraepithelial neoplasia, high level amplifications have been detected on chromosomes 7q, 8p, 13q, 17q and 20q \[[@B13]-[@B16]\]. In gastric adenocarcinomas, consistently described chromosomal aberrations are gains on chromosome 3q, 7p, 7q, 8q, 13q, 17q and 20q and losses on chromosome 4q, 5q, 6q, 9p, 17p and 18q. High level amplifications have been repeatedly detected on 7q, 8p, 8q, 17q, 19q and 20q \[[@B14],[@B17]-[@B23]\]. Yet, chromosomal aberrations, or DNA copy number changes, are not uniform in gastric cancer \[[@B24]\]. Subgroups with different patterns of DNA copy number alterations can be recognized, which have been shown to be associated with clinical outcome as well \[[@B25]\].

In the present study, we set out to study whether two morphologically distinct categories of gastric cancer precursor lesions, i.e. intestinal-type and pyloric gland adenomas, would carry different patterns of DNA copy number changes, possibly reflecting distinct genetic pathways of gastric carcinogenesis in the two adenoma types.

Results
=======

DNA copy number changes were observed in 10 out of 11 intestinal-type adenomas and 9 out of 10 pyloric gland adenomas. The mean number of chromosomal events, defined as gains and losses, per tumour was 6.0 (range 0--18), including 2.9 (range 0--14) gains and 3.0 (range 0--7) losses. In intestinal-type adenomas, the mean number of chromosomal events per tumour was 6.5 (range 0--18) of which 3.4 (range 0--14) gains and 3.1 (range 0--7) losses, and in the pyloric gland adenomas the mean numbers were 5.4 (range 0--9), 2.4 (range 0--7) and 3.0 (range 0--7) respectively.

In the intestinal-type gastric adenomas, the most common aberrations observed were gains on chromosomes 8, 9q and 11q, and losses on chromosomes 5q, 6, 10 and 13. In four adenomas (36.4%), gain of chromosome 11q23.3 was observed with a common region of overlap of 2.6 Mb. Gain of chromosome 9q was observed in four adenomas (36.4%) with a 12.6 Mb common region of overlap located on chromosome 9q33.1-q34.13. Gain of chromosome 8 was observed in three adenomas (31%), two of which adenomas showed gain of whole chromosome 8, and the third adenoma showed a gain of chromosome 8p-q22.3 with an additional 28.7 Mb gain on chromosome 8q24.11-qter. In addition, gains were observed on chromosomes 1, 3, 6p, 7, 11p, 12p, 13q, 16, 17, 19, 20 and 22q. No amplifications were seen in the intestinal-type adenomas.

Deletions on chromosome 13 were observed in seven intestinal-type adenomas (64%). Of these, five showed a 11.9 Mb deletion of chromosome 13q21.2-21.33 with an additional 7.7 Mb deletion on chromosome 13q31.1-31.3. The other two adenomas showed a 16.6 Mb deletion of 13q14.3-31. A deletion on chromosome 6 was observed in six adenomas (55%), with an overlapping region of 68.9 Mb located on 6cen-q22.1. A deletion of chromosome 5q was observed in four adenomas (36%) with a common region of overlap located on chromosome 5q22.1-q23.2. In addition, a deletion of whole chromosome 10 was observed in four adenomas (36%). Other losses observed in intestinal-type adenomas were located on chromosomes 8q, 9p, 10, 12q, 20q and 21. An overview of all DNA copy number aberrations of the intestinal-type adenomas is shown in Table [1](#T1){ref-type="table"}.

###### 

Overview of the DNA copy number changes in 11 intestinal-type adenomas

       **Chromosomal aberrations**                    **Flanking clones**                 
  ---- ----------------------------- ---------------- --------------------- ------------- -------------
  1    1p-p36.11                                      26.68                 RP11-465B22   RP1-159A19
                                     5q13.2-q23.2     55.26                 RP11-115I6    CTB-1054G2
       6p21.33-p21.1                                  13.78                 RP11-346K8    RP11-227E22
                                     6p21.1-q16.1     52.05                 RP11-89I17    RP3-393D12
       9q33.1-34.2                                    17.32                 RP11-27I1     RP11-417A4
       11q23.3                                        4.80                  RP11-4N9      RP11-730K11
                                     13q21.1-q31.3    39.63                 RP11-200F15   RP11-62D23
                                                                                          
  2    1p-1p33                                        46.90                 RP11-465B22   RP11-330M19
       6p21.33-p21.1                                  14.12                 RP11-346K8    RP11-121G20
                                     6p21.1-q16.2     54.91                 RP11-554O14   RP11-79G15
       8p-q22.3                                       105.67                GS1-77L23     RP11-200A13
       8q24.11-qter                                   28.65                 RP11-278L8    RP5-1056B24
       9q33.1-q34.2                                   13.63                 RP11-85O21    RP11-417A4
       11p11.2-q13.5                                  31.69                 RP11-58K22    RP11-30J7
       11q23.3                                        2.62                  RP11-4N9      RP11-62A14
       12q13.11-q14.1                                 10.57                 RP11-493L12   RP11-571M6
                                     13q21.1-q21.33   18.24                 RP11-200F15   RP11-335N6
                                     13q31.1-q31.3    12.49                 RP11-533P8    RP11-62D23
       16p13.3-q21                                    57.26                 RP11-243K18   RP11-405F3
                                     16q21-q22.1      5.97                  RP11-105C20   RP11-298C15
       16q22.1-q24.3                                  22.46                 RP11-63M22    CTC-240G10
       17                                             81.24                 GS1-68F18     RP11-567O16
       19                                             61.01                 CTB-1031C16   GS1-1129C9
       20q11.21-q11.23                                5.09                  RP3-324O17    RP5-977B1
       20q13.12-qter                                  19.60                 RP1-138B7     CTB81F12
                                                                                          
  3    \-                            \-                                                   
                                                                                          
  4    6p21.1                                         3.32                  RP11-79J5     RP11-121G20
                                     6p12.3-q22.1     76.38                 RP11-79G12    RP11-59D10
       7                                              156.89                RP11-510K8    CTB-3K23
                                     8q22.3-q23.3     9.69                  RP11-142M8    RP11-261F23
       9q33.1-q34.13                                  12.58                 RP11-55P21    RP11-83N9
       11q23.3                                        3.04                  RP11-4N9      RP11-8K10
                                     13q21.2-q21.33   17.05                 RP11-240M20   RP11-77P3
                                     13q31.1-q31.3    11.68                 RP11-400M8    RP11-100A3
       16q23.2-q24.3                                  8.92                  RP11-303E16   RP4-597G12
       20p-q13.2                                      53.40                 CTB-106I1     RP5-1162C3
       20q13.31-qter                                  8.06                  RP5-1167H4    CTB-81F12
       22q                                            33.72                 XX-P8708      CTB-99K24
                                                                                          
  5                                  12q24.31-qter    11.75                 RP11-322N7    RP11-1K22
                                                                                          
  6    3                                              193.37                RP11-299N3    RP11-279P10
                                     6cen-q24.1       88.49                 RP11-91E17    RP11-86O4
       7                                              156.09                RP11-510K8    RP11-518I12
       8                                              144.26                RP11-91J19    RP5-1118A7
                                     13q21.1-q21.33   11.86                 RP11-640E11   RP11-452P23
                                     13q31.1-q31.3    9.62                  RP11-400M8    RP11-306O1
                                     20q13.2-q13.31   1.41                  RP11-212M6    RP4-586J11
                                                                                          
  7                                  5q21.1-qter      80.52                 CTC-1564E20   RP11-281O15
                                     10               132.19                RP11-29A19    RP11-45A17
       13q21.33-31.1                                  8.76                  RP11-209P2    RP11-470M1
                                                                                          
  8                                  5q22.1-q23.2     13.28                 RP11-276O18   RP11-14L4
                                     6p12.3-q22.1     74.37                 RP11-89l17    RP11-149M1
                                     9p21.1-pter      31.18                 RP11-147I11   RP11-12K1
                                     10               133.18                RP11-10D13    RP11-45A17
                                     13q14.3-q31.3    39.71                 RP11-211J11   RP11-306O1
       17                                             77.65                 GS1-68F18     RP11-398J5
       19                                             63.31                 CTC-546C11    CTD-3138B18
       20                                             60.87                 RP4-686C3     RP4-591C20
       22q                                            31.25                 XX-bac32      CTA-722E9
                                                                                          
  9                                  5q14.3-q23.2     33.06                 RP11-302L17   RP11-14L4
                                     6p22.2-q22.3     8.44                  RP11-91n3     RP11-88h24
                                     6p12.1-q24.1     88.89                 RP11-7h16     RP11-368P1
       8                                              145.95                GS1-77L23     CTC-489D14
       9q33.1-qter                                    13.60                 RP11-91G7     GS1-135I17
                                     10               133.18                RP11-10D13    RP11-45A17
       11q23.3                                        3.16                  RP11-4N9      RP11-215D10
                                     13q14.3-qter     58.59                 RP11-240M20   RP11-480K16
                                     20q13.2-q13.31   1.96                  RP11-55E1     RP5-832E24
                                     21cen-q21.3      17.39                 RP11-193B6    RP11-41N19
                                                                                          
  10                                 8q22.3-q23.3     12.93                 RP11-142M8    RP11-143P23
                                     10               134.52                RP11-10D13    RP11-122K13
                                     13q21.1-q21.33   18.03                 RP11-322F18   RP11-335N6
                                     13q31.1-q31.3    8.99                  RP11-533P8    RP11-505P2
                                                                                          
  11   \-                            \-                                                   

The most frequent aberration observed in pyloric gland adenomas were gains on chromosome 20 and losses on chromosomes 5q and 6. Gains on chromosome 20 were seen in four adenomas (40%). Three adenomas showed a 9.8 Mb gain of chromosome 20q13.12-q13.33, and gain of whole chromosome 20 was observed in the other adenoma. In addition, gains were seen on chromosomes 1, 3q, 5q, 7, 9q, 11q, 12q, 13q, 15q, 17 and 22q. One pyloric gland adenoma showed amplifications, located on 12q13.2-q21.1 and 20q13.3-q13.33.

Five pyloric gland adenomas (50%) showed loss of chromosome 5q, two of which had lost a whole chromosome arm, while two adenomas showed a 22.4 Mb deletion of 5q11.2-q13.3 and one adenoma a 40.3 Mb deletion of 5q21.1-q31.2. Loss of chromosome 6 was observed in four pyloric gland adenomas (40%), three of which showed a complete loss of 6q and one adenoma showed a 51.2 Mb deletion of 6p21.1-q16.3. Other chromosomal losses were observed on chromosomes 1p, 2q, 4, 9p, 10, 12q 13q, 14q, 16, 18q, 20q, and 21. An overview of DNA copy number aberrations of the pyloric gland adenomas is shown in Table [2](#T2){ref-type="table"}.

###### 

Overview of the DNA copy number changes in 10 pyloric gland adenomas

       **Chromosomal aberrations**                        **Flanking clones**                 
  ---- --------------------------------- ---------------- --------------------- ------------- -------------
  12   1q21.3-q23.3                                       9.95                  RP11-98D18    RP11-5K23
       1q42.13-q43                                        14.07                 RP11-375H24   RP11-80B9
       3q                                                 111.59                RP11-312H1    RP11-23M2
       5q35.1-q35.3                                       9.11                  RP11-20O22    RP11-451H23
                                         6q               115.76                RP11-524H19   RP5-1086L22
       7                                                  156.09                RP11-510K8    RP11-518I12
       17                                                 77.48                 RP11-4F24     RP11-313F15
       20                                                 63.47                 CTB-106I1     CTB-81F12
                                                                                              
  13   \-                                \-                                                   
                                                                                              
  14                                     4                191.13                CTC-963K6     RP11-45F23
                                         5q               128.59                CTD-2276O24   RP11-281O15
                                         14q              83.81                 RP11-98N22    RP11-73M18
                                         16               89.71                 RP11-344L6    RP4-597G12
       20q13.2-q13.33                                     10.84                 RP4-724E16    CTB-81F12
                                                                                              
  15   9q33.2-q34.3                                       16.81                 RP11-57K1     RP11-83N9
       11q23.2-q24.3                                      16.04                 RP11-635F12   RP11-567M21
       12q14.3-q15                                        2.58                  RP11-30I11    RP11-444B24
       20q13.31-q13.33                                    6.86                  RP5-1153D9    RP5-963E22
       22q                                                32.53                 XX-p8708      CTA-722E9
                                                                                              
  16   9q33.3-qter                                        13.57                 RP11-85C21    GS1-135I17
                                         10p12.1-qter     110.28                RP11-379L21   RP11-45A17
       11q23.1-q24.3                                      17.72                 RP11-107P10   RP11-567M21
                                         13q31.1-q32.1    10.84                 RP11-661D17   RP11-40H10
                                         20q13.2-q13.31   1.96                  RP11-55E1     RP4-586J11
                                                                                              
  17                                     1p34.3-pter      35.59                 RP1-37J18     RP11-204L3
       1p33-qter                                          203.62                RP4-739H11    RP11-551G24
                                         2q31.1-qter      66.00                 RP11-205B19   RP11-556H17
                                         5q21.1-q31.2     40.27                 CTD-2068C11   RP11-515C16
       5q31.3-qter                                        39.06                 CTD-2323H12   RP11-451H23
                                         6q               113.61                RP11-89D6     CTB-57H24
                                         10               134.52                RP11-10D13    RP11-122K13
                                         13q31.1-qter     36.14                 RP11-388E20   RP11-245B11
                                         20q13.2-qter     11.24                 RP11-15M15    RP5-1022E24
                                                                                              
  18                                     5q11.2-q21.2     51.24                 CTC-1329H14   RP1-66P19
                                         6p12.1-q16.3     51.24                 RP11-7H16     RP11-438N24
                                         9pter-q13        66.82                 GS1-41L13     RP11-265B8
                                         10               133.04                RP11-10D13    RP11-45A17
                                         13q21.1-q21.33   18.39                 RP11-240M20   RP11-335N6
                                         13q31.1-q31.3    12.45                 RP11-551D9    RP11-100A3
                                         21cen-q21.3      17.39                 RP11-193B6    RP11-41N19
                                                                                              
  19                                     1p32.3-p21.1     50.40                 RP11-117D22   RP5-1108M17
                                         5q11.2-q13.3     24.64                 RP4-592P18    CTD-2200O3
       13q12.11-q14.3                                     31.58                 RP11-187L3    RP11-327P2
       15q12-q26.3                                        77.21                 RP11-131I21   CTB-154P1
                                         18q21.1-q23      31.31                 RP11-46D1     RP11-154H12
       22q13.2-qter                                       10.02                 CTA-229A8     CTA-799F10
                                                                                              
  20                                     9p-q13           66.57                 GS1-41L13     RP11-274B18
       12q13.2-q21.1 (amplification)                      19.50                 RP11-548L8    RP11-255I14
                                         12q21.2-qter     55.56                 RP11-25J3     RP11-1K22
                                         18q21.31-q23     23.28                 RP11-383D22   CTC-964M9
       20q13.13-q13.33 (amplification)                    14.62                 RP5-1041C10   RP5-1022E24
                                                                                              
  21   5p                                                 43.15                 CTD-2265D9    RP11-28I9
                                         5q               130.26                RP11-269M20   RP11-451H23
       6p                                                 62.57                 CTB-62I11     RP11-506N21
                                         6q               106.73                RP11-767J14   RP5-1086L22

The most common aberrations shared by both intestinal-type and pyloric gland adenomas were gain of chromosome 9q (29%), 11q (29%), and 20q (33%) and loss of chromosome 5 (43%), 6 (48%), 10 (33%) and 13q (48%). By comparing intestinal-type and pyloric gland adenomas, CGH Multiarray revealed eight clones to be significantly different, six of which were located at chromosome 6q14-q21 (p = 0.02 to 0.05) and two clones on chromosome 9p22-p23 (p = 0.02 and 0.04, respectively) (Figure [1](#F1){ref-type="fig"}). No genes located in the regions covered by these clones have been known to be involved in cancer related biological processes. Yet, CGH Multiarray Region, after correction for multiplicity, yielded a false discovery rate (FDR) of 1 for all these regions, indicating no significant differences between the two different types of adenomas at the chromosomal level. Unsupervised hierarchical cluster analysis yielded 2 clusters. No significant associations were found here (p = 0.8).

![Comparison of DNA copy number alterations in intestinal and pyloric gland type gastric adenomas. A p-value (Y-axis) was calculated for every clone, based on a Wilcoxon test with ties, and plotted in chromosomal order from chromosome 1 to 22 (X-axis). Eight clones reached the level of significance (p \< 0.05), but failed to maintain a significantly low false discovery rate after correction for multiple comparison.](1471-2164-8-345-1){#F1}

Discussion
==========

Given the heterogeneous phenotype of gastric cancer, the present study primarily aimed to compare copy number changes between intestinal-type adenomas and pyloric gland adenomas, in order to find leads towards genetic pathways involved in the pathogenesis of gastric cancer. Adenoma-to-carcinoma progression is observed in 30--40% of the pyloric gland adenomas and in approximately 5--30% of the intestinal-type adenomas (varying from about 5% in tubular adenomas to almost 30% for tubulovillous and villous adenomas) \[[@B9]-[@B11]\], indicating the direct malignant potential of these two adenoma types and making gastric adenomas a suitable model for detecting early events in gastric carcinogenesis.

Pyloric gland adenomas constitute a recently recognized entity \[[@B8],[@B26]\]. To the best of our knowledge, this type of adenomas has never been analyzed by array CGH before. The mean number of events in this type of adenoma was 5.4 (0--9), with 2.4 (0--7) gains and 3 (0--7) losses. This is comparable with the mean number of aberrations in intestinal-type adenomas (6.5 (0--18), 3.4 (0--14) and 3.1 (0--7) respectively). In pyloric gland adenomas, frequent events were gain on chromosome 20 and losses on chromosomes 5q and 6, while intestinal-type adenomas mainly showed gain on chromosomes 8, 9q, and 11q, and losses on chromosomes 5q, 6, 10 and 13. In the present study, gain of chromosome 7 was less common than found previously \[[@B16]\]. Although these frequently altered regions differ between the two types of adenomas, hierarchical cluster analyses did not separate the groups. In addition, CGH Multiarray Region did not reveal any significant differences after correction for multiple comparisons. This lack of statistically significant differences could be due to the limited sample size combined with the fact that in general, adenomas show little chromosomal aberrations. On the other hand, it could simply be that these morphologically different entities do not differ in terms of chromosomal gains and losses. Finding no significant differences at the chromosomal level does not preclude other genetic and biological differences such as mutation or promoter methylation status of specific genes.

Aberrations already detected in adenomas may be early events in the stepwise process of accumulating changes which may cause progression of adenoma to carcinoma. As expected, the mean number of chromosomal events was lower in adenomas compared to the carcinomas \[[@B13],[@B14],[@B27]\]. Moreover, high level amplifications are uncommon in adenomas, while carcinomas frequently show high level amplifications \[[@B13],[@B16]\].

The aberrations found in both intestinal-type and pyloric gland adenomas, such as losses on chromosome 5q, are also frequently detected in gastric carcinomas \[[@B15],[@B19],[@B28]\]. Previous CGH results showed a significantly higher number of chromosome 5q losses in intestinal-type carcinoma compared to diffuse type carcinoma \[[@B29]\]. Chromosome 6, also lost in both types of adenomas, frequently is deleted in gastric carcinomas as determined by LOH studies \[[@B30],[@B31]\]. Moreover, chromosome 6q deletion has been reported to be involved in an early stage of gastric carcinogenesis, since chromosome 6q deletions are frequently detected in early gastric cancer and also in intestinal metaplasia \[[@B31],[@B32]\]. Losses of chromosomes 10 and 13 have been previously observed in adenomas at lower frequencies. In gastric carcinomas, both gains and losses of chromosome 10 and 13 have been observed by previous CGH studies \[[@B15],[@B19],[@B21],[@B33]\]. Chromosome 10 harbors the oncogene *FGFR2*(10q26) and tumour suppressor genes *PTEN/MMAC1*(10q23) and *DMBT1*(10q25-q26), both involved in carcinogenesis, which could explain the observation of both gains and losses of chromosomes 10 in gastric carcinomas \[[@B34]-[@B36]\]. Indeed chromosome 13 harbors tumour suppressor genes such as *BRCA2*(13q12.3) and retinoblastoma gene (*RB1*) (13q14). In contrast, gain of chromosome 13q has been correlated to colorectal adenoma-to-carcinoma progression, and amplification of chromosome 13 has been observed in gastric adenomas with severe intraepithelial neoplasia \[[@B14],[@B37]\]. The precise role of chromosome 13 aberration in gastric cancer therefore remains to be resolved.

Most frequent copy number gains were observed on chromosomes 8, 9q, 11q and 20. Especially gains of chromosomes 8 and 20 are consistent with previous (array) CGH studies in both gastric adenomas and gastric carcinomas \[[@B13]-[@B16],[@B19],[@B25]\], implicating this as early events in tumourigenesis. Although gain of chromosome 11q has not been described as a frequent event in adenomas, in carcinomas gain or amplification on chromosome 11q is common \[[@B13]-[@B16]\]. In the present study gain of chromosome 11q was frequently observed in the adenomas, implying the malignant potential of these adenomas.

Conclusion
==========

These data indicate that gains on chromosomes 8, 9q, 11q and 20 and losses on chromosomes 5q, 6, 10 and 13 are early events in gastric carcinogenesis. Despite the phenotypical differences, intestinal-type and pyloric gland adenoma do not differ significantly at the level of DNA copy number changes.

Methods
=======

Material
--------

Twenty-one paraffin-embedded gastric adenomas, 11 intestinal-type and 10 pyloric gland adenomas, were included in this study (Figure [2A](#F2){ref-type="fig"} and [2B](#F2){ref-type="fig"}). Tumour and patient data are given in Table [3](#T3){ref-type="table"}. For each case, a tumour area consisting for at least 70% of tumour cells was demarcated on a 4 μm hematoxylin and eosin stained tissue section. Adjacent 10--15 serial tissue sections of 10 μm were stained with hematoxylin and the corresponding tumour area was microdissected using a surgical blade. A final 4μm \"sandwich\" section was made and stained with hemotoxylin and eosin, to compare with the first slide as a control. After deparaffinization, DNA was extracted by a column-based method (QIAamp DNA mini kit; Qiagen, Westburg, Leusden, NL) \[[@B38]\].

###### 

Tumour and patient information

  **Tumour ID**   **Adenoma type**   **Grade of dysplasia**   **Gender**   **Age**   **Tumour ID**   **Adenoma type**   **Grade of dysplasie**   **Gender**   **Age**
  --------------- ------------------ ------------------------ ------------ --------- --------------- ------------------ ------------------------ ------------ ---------
  1               Intestinal         Moderate                 Male         75        12              Pyloric gland      Moderate                 Male         78
  2               Intestinal         Moderate                 Male         45        13              Pyloric gland      Mild                     Male         50
  3               Intestinal         Moderate                 Male         80        14              Pyloric gland      Severe                   Female       76
  4               Intestinal         Moderate                 Male         79        15              Pyloric gland      Moderate                 Female       85
  5               Intestinal         Moderate                 Male         76        16              Pyloric gland      Moderate                 Male         63
  6               Intestinal         Moderate                 Male         75        17              Pyloric gland      Mild                     Female       86
  7               Intestinal         Mild                     Male         57        18              Pyloric gland      Moderate                 Female       59
  8               Intestinal         Moderate                 Male         64        19              Pyloric gland      Moderate                 Male         69
  9               Intestinal         Mild                     Male         63        20              Pyloric gland      Moderate                 Female       78
  10              Intestinal         Mild                     Male         75        21              Pyloric gland      Moderate                 Male         ?
  11              Intestinal         Moderate                 Female       45                                                                                 

![Haematoxilin and eosin staining (original magnification ×400) of intestinal-type (A) and pyloric gland (B) gastric adenomas. A. Intestinal-type adenoma of the stomach composed of irregularly arranged glands composed of intestinal-type epithelium with eosinophilic cytoplasm and enlarged nuclei. B. Pyloric gland adenoma of the stomach composed of densely back to back packed glands consisting of cells with pale cytoplasm and small round hyperchromatic nuclei.](1471-2164-8-345-2){#F2}

Genomic DNA obtained from peripheral blood from ten normal individuals was pooled (either ten females or ten males, depending on the gender of the patient from which the adenoma was obtained) and used as control reference DNA.

Array CGH

Array CGH was performed essentially as described previously \[[@B39]\]. Briefly, 300 ng tumour and reference DNAs, sex-mismatch as experimental control, were labelled by random priming (Bioprime DNA Labelling System, Invitrogen, Breda, NL), each in a volume of 50μL. Non incorporated nucleotides were removed using ProbeQuant G-50 microcolumns (Amersham Biosciences). Cy3 labelled test genomic DNA and Cy5 labelled reference DNA were combined and co-precipitated with 100μg of human Cot-1 DNA (Invitrogen, Breda, NL) by adding 0.1 volume of 3 M sodium acetate (pH 5.2) and 2.5 volumes of ice-cold 100% ethanol. The precipitate was collected by centrifugation at 14,000 rpm for 30 minutes at 4°C, and dissolved in 130 μl hybridization mixture containing 50% formamide, 2 × SCC and 4% SDS. The hybridization solution was heated for 10 minutes at 73°C to denature the DNA, followed by 60--120 minutes incubation at 37°C to allow the Cot-1 DNA to block repetitive sequences. The mixture was hybridized on an array containing approximately 5000 clones spotted in triplicate and spread along the whole genome with an average resolution of 1.0 Mb. The clones are comprised of the Sanger BAC clone set with an average resolution along the whole genome of 1.0 Mb \[[@B40]\], the OncoBac set \[[@B41]\], and selected clones of interest, obtained from the Children\'s Hospital Oakland Research Institute (CHORI). The selected clones comprise a collection of BAC clones on chromosome 6 filling the gaps larger than 1 Mb, and full-coverage contigs on specific regions on chromosomes 8, 13 and 20. Hybridization was performed in a in a hybridization station (Hybstation12 -- Perkin Elmer Life Sciences, Zaventem, BE) and incubated for 38 h at 37°C. After hybridization, slides were washed in a solution containing 50% formamide, 2× SCC, pH 7 for 3 minutes at 45°C, followed by 1 minute wash steps at room temperature with PN buffer (PN: 0.1 M sodiumphosphate, 0.1% nonidet P40, pH 8), 0.2× SSC, 0.1× SCC and 0.01× SCC.

Image acquisition and data analysis
-----------------------------------

Images of the arrays were acquired by scanning (Agilent DNA Microarray scanner- Agilent technologies, Palo Alto, USA) and quantification of the signal and background intensities for each spot for the two channels Cy3 and Cy5 was performed by Imagene 5.6 software (Biodiscovery Ltd, Marina del Rey, CA, USA). Local background was subtracted from the signal median intensities and tumours to reference ratios were calculated. The ratios were normalized against the mode of the ratios of all autosomes. Clones with poor quality of one of the triplicates and hybridization with a standard deviation (SD) ≤ 0.22 and clones with \> 50% missing values in all adenomas were excluded, leaving 4648 clones for further analysis. All subsequent analyses were done considering the clone position from the UCSC May2004 freeze of the Human Golden Path.

Array CGH smooth \[[@B42],[@B43]\], was used for automated detection of breakpoints to determine copy number gains and losses. Since variation in quality is observed in DNA obtained from formalin-fixed paraffin-embedded gastric tissues, different smoothing parameters were applied, depending on the quality of the hybridization. For array CGH profiles with a standard deviation smaller or equal to 0.15, between 0.15 and 0.20 or between 0.20 and 0.22, the applied smoothing parameters to determine gains and losses were 0.10, 0.15 and 0.20 respectively. Log~2~tumour to reference ratio above 1 was regarded as amplification.

Statistical analysis
--------------------

Unsupervised hierarchical cluster analysis was performed to analyze the distributions of the genomic profiles of all adenomas using TMEV software 3.0.3 \[[@B44]\]. Based on normalized smoothed log~2~tumour to normal fluorescence intensity ratios, a hierarchical tree was constructed using the parameters complete linkage and euclidean distance. Pearson Chi-square test was used for analyzing correlations between cluster membership and adenoma type (SPSS 11.5.0 for windows, SPSS Inc, Chicago, IL, USA). P-values less than 0.05 were considered to be significant.

Supervised analysis was used for identifying chromosomal regions specific for the two adenoma types using CGH Multiarray and CGH Multiarray Region \[[@B45],[@B46]\]. Based on normalized smoothed log~2~tumour to normal fluorescence intensity ratios, p-values were calculated for the significance of difference of values for each clone between pyloric gland and intestinal-type adenomas, using a Wilcoxon test with ties. To correct for multiple testing, a permutation-based false discovery rate (FDR) was calculated \[[@B47]\].
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